News

Maxine Morand Board Chair
General news

Meet Board Chair Maxine Morand - IWD 2018

March 6, 2018
Peter Mac’s Board Chair Maxine Morand is a passionate advocate for women’s equality of opportunity. Today, on International Women’s Day, she is adding her voice to the global campaign for gender parity. And her message is simple: Constantly call out where you see inequality. Here, she explains what drives her to speak out for equality. #PressforProgress #IWD2018
Read more
Shatha Abuhammad, Scientist
General news

Meet Scientist Shatha Abuhammad - IWD 2018

March 6, 2018
Shatha is a young, up-and-coming researcher who started her career as a dentist in Jordan. Shatha recently submitted her PhD investigating how cancers like melanoma become resistant to certain therapies. She is also working on developing new drug combination that can overcome the resistance and improve the response to treatment. Her persistence, passion and drive to work with the leaders in her field led her to Peter Mac. Shatha explains her inspiration and what it takes to succeed in research. #PressforProgress #IWD2018
Read more
Laura Pumo, Manager of Admissions, Registrations, Switchboard and Transport
General news

Meet Laura Pumo, Manager Admissions and Transport - IWD 2018

March 6, 2018
At 25, Laura Pumo is one of Peter Mac’s youngest managers. She is responsible for a 27-strong team of admissions, registrations, switchboard and transport staff, who play an important role in helping patients, families and visitors to access our world-leading cancer services. Laura is a naturally confident and calm leader, with an ability to quickly build rapport. She’s a classic people person, with an analytical mind. In the lead up to International Women's Day, Laura explains how she got to where she is today. #PressforProgress #IWD2018
Read more
Maria Ftanou
General news

Meet Lead Clinical Psychologist Maria Ftanou - IWD 2018

March 6, 2018
As Lead Clinical Psychologist in Peter Mac’s Psychosocial Oncology Program Maria Ftanou leads a team of clinical psychologists who work with Peter Mac patients and their families across all types and stages of cancer, from those at risk to long-term survivors or in end-of-life care. Maria combines her leadership role with seeing her own clients, working as a research fellow at the University of Melbourne, as well as undertaking a PhD. In the lead up to International Women's Day, Maria explains how mentor-mentee relationships have sustained and inspired her, and why they are integral to her success. #PressforProgress #IWD2018
Read more
Nicole Tweddle, Chief Operating Officer
General news

Meet our Chief Operating Officer Nicole Tweddle - IWD 2018

March 6, 2018
Peter Mac’s Chief Operating Officer (COO) Nicole Tweddle is a changemaker. She is a person who knows how to ask the right questions, connect the dots, form relationships, understand the impacts of making a change and the consequences of maintaining the status quo. She is one of six women in Peter Mac’s Executive Team, a position she has earned through tenacity, hard work and humility. Here, she explains what it takes to be a woman at the top of her game. Join us as we #PressforProgress on International Women's Day #IWD2018
Read more
General newsResearch

RESEARCH INTO RARE CANCERS RECEIVES FUNDING BOOST

March 1, 2018
A team of researchers, led by Peter Mac’s Prof Rod Hicks, has been awarded a $1.5 million grant from the US-based Neuroendocrine Tumour Research Foundation (NETRF) to study new treatment approaches for this rare and difficult to treat cancer.
Read more
General newsPatient & carer stories

Pet therapy at Peter Mac

February 28, 2018
You know its Wednesday when Baz the Spoodle patters through the Peter Mac corridors. Wearing his official ‘pet therapy’ uniform, the volunteer pup and his owner Cath Flanagan bring a weekly dose of joy to patients and staff.
Read more
Research

TRACING BACK IN TIME TO FIND BRCA MUTATION CARRIERS

February 8, 2018
The Federal Government has committed $2.96 million to fund TRACEBACK, aimed at identifying unaware carriers of BRCA gene mutations and preventing future cases of ovarian and other cancers. The announcement was made this week to mark Ovarian Cancer Awareness Month.
Read more
General newsResearchClinical research & trials

Ground-breaking research changes diagnosis for rare bone marrow disorder

February 2, 2018
A new genomics test developed and performed at Peter Mac is changing the way a rare bone marrow disorder, which can turn into an aggressive blood cancer, is diagnosed.
Read more
Professor Sherene Loi, head of the Translational Breast Cancer Genomics Laboratory at Peter Mac
ResearchClinical research & trials

TRIAL REVEALS IMPORTANCE OF HER2 AND HER3 MUTATIONS

February 1, 2018
An international study involving Peter Mac patients is the first in the world to clinically characterise the therapeutic importance of a diverse set of mutations affecting the HER2 and HER3 proteins.
Read more